Federica Giordano, PhD

As the Associate Director of Operations at March Biosciences, I specialize in the development and clinical translation of CAR T-cell therapies for hematological malignancies, leveraging my expertise in oncology and cancer biology. 

With a decade of experience in oncology research and development, my focus has encompassed pre-clinical research, therapeutic target validation, and the innovative application of biomimetic nanoparticles for solid tumor treatment. 

With great scientific communication and strategic collaborations, I am committed to enhancing patient care through advanced therapeutic solutions. My advocacy for patient access to novel treatments and clinical trials underscores a passion for bridging the gap between research and real-world applications, aiming to revolutionize cancer care with patient-centric and innovative approaches.